Leo Wealth, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Leo Wealth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 23, 2025	BUY	$483.07 - $625.6 $225,593 - $292,155	467 Added 39.61%	1,646 $864 Million
Q1 2025 May 02, 2025	BUY	$634.14 - $744.83 $344,972 - $405,187	544 Added 85.67%	1,179 $748 Million
Q4 2024 Jan 27, 2025	SELL	$701.85 - $1046.91 $263,895 - $393,638	-376 Reduced 37.19%	635 $452 Million
Q3 2024 Oct 21, 2024	BUY	$1024.09 - $1201.76 $110,601 - $129,790	108 Added 11.96%	1,011 $1.06 Billion
Q2 2024 Jul 17, 2024	BUY	$883.2 - $1071.19 $797,529 - $967,284	903 New	903 $949 Million

1,490

86.4M

2.38M

1.61M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Leo Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Leo Wealth, LLC with notifications on news.